Application
Deshydroxy LY-411575 has been used in dibenzazepine (DBZ) treatment and chemical treatment.
Biochem/physiol Actions
LY411575 prevents SPP (signal peptide peptidase) dependent cleavage of HCV (hepatitis C virus) core protein.
Deshydroxy LY-411575 is a cell-permeable γ-secretase inhibitor and inhibtor of Notch processing. Deshydroxy LY-411575 significantly lowers both brain and plasma Aβ40 levels by ~72% in Tg2576 mutant APP transgenic mouse model and potently blocks Notch processing, with an IC50 of 1.7 nM in SupT1 cells.
Packaging
5, 25 mg in glass bottle
This product has met the following criteria to qualify for the following awards: